At the FDA hearing on Avastin on June 28, up to 2 hours have been reserved for public presentations. If you wish to make an oral presentation during this hearing, you must register by submitting an electronic or written request by May 27, to:
Talisha Williams
Office of the Ombudsman, Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave
Silver Spring, MD 20993
301-796-8530
email:
Talisha.Williams@fda.hhs.gov
Depending on the number of requests, FDA may not be able to honor all such requests. You must provide your name, title, business affiliation (if applicable), address, telephone and FAX numbers, email address, and (if applicable) type of organization you represent (e.g., industry, consumer organization). You also should submit a brief summary of the presentation, including the discussion topic(s) that will be addressed and the approximate time requested for your presentation.
FDA Hearing Info
FDA hearing June 28 re: AVASTIN
Threaded Mode